Sutton Wealth Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
RCMNY
GACM
TSW
EA
ACM
Sutton Wealth Advisors's ANIP Position: Q1 2023 in Review
Sutton Wealth Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2023, closing a stake of 4 shares — an estimated $161 sold.
Sutton Wealth Advisors first reported a position in ANIP in Q1 2016 and held it in 28 quarters. The position peaked at $19.5K in Q2 2019. 138 funds tracked by Wall St. Rank hold ANIP as of Q1 2023.
- Sutton Wealth Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
- Sutton Wealth Advisors sold 4 ANI Pharmaceuticals shares in Q1 2023, an estimated $161.
- Sutton Wealth Advisors first reported a position in ANI Pharmaceuticals in Q1 2016 and held it in 28 quarters.
- Sutton Wealth Advisors's ANI Pharmaceuticals position peaked at $19.5K in Q2 2019.
- 138 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2023.
Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.